BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20130678)

  • 1. Structural and functional implications of phosphorylation and acetylation in the regulation of the AAA+ protein p97.
    Ewens CA; Kloppsteck P; Förster A; Zhang X; Freemont PS
    Biochem Cell Biol; 2010 Feb; 88(1):41-8. PubMed ID: 20130678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p97/valosin-containing protein (VCP) is highly modulated by phosphorylation and acetylation.
    Mori-Konya C; Kato N; Maeda R; Yasuda K; Higashimae N; Noguchi M; Koike M; Kimura Y; Ohizumi H; Hori S; Kakizuka A
    Genes Cells; 2009 Apr; 14(4):483-97. PubMed ID: 19335618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Going through the motions: the ATPase cycle of p97.
    Pye VE; Dreveny I; Briggs LC; Sands C; Beuron F; Zhang X; Freemont PS
    J Struct Biol; 2006 Oct; 156(1):12-28. PubMed ID: 16621604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change.
    Davies JM; Brunger AT; Weis WI
    Structure; 2008 May; 16(5):715-26. PubMed ID: 18462676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97.
    Schuberth C; Buchberger A
    Cell Mol Life Sci; 2008 Aug; 65(15):2360-71. PubMed ID: 18438607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the aggregation-prevention activity of p97/valosin-containing protein.
    Song C; Wang Q; Li CC
    Biochemistry; 2007 Dec; 46(51):14889-98. PubMed ID: 18044963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains.
    DeLaBarre B; Brunger AT
    Nat Struct Biol; 2003 Oct; 10(10):856-63. PubMed ID: 12949490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nucleotide dependent motion and mechanism of action of p97/VCP.
    DeLaBarre B; Brunger AT
    J Mol Biol; 2005 Mar; 347(2):437-52. PubMed ID: 15740751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubxd1 is a novel co-factor of the human p97 ATPase.
    Madsen L; Andersen KM; Prag S; Moos T; Semple CA; Seeger M; Hartmann-Petersen R
    Int J Biochem Cell Biol; 2008; 40(12):2927-42. PubMed ID: 18656546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational changes of p97 during nucleotide hydrolysis determined by small-angle X-Ray scattering.
    Davies JM; Tsuruta H; May AP; Weis WI
    Structure; 2005 Feb; 13(2):183-95. PubMed ID: 15698563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47.
    Dreveny I; Kondo H; Uchiyama K; Shaw A; Zhang X; Freemont PS
    EMBO J; 2004 Mar; 23(5):1030-9. PubMed ID: 14988733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.
    Weihl CC; Dalal S; Pestronk A; Hanson PI
    Hum Mol Genet; 2006 Jan; 15(2):189-99. PubMed ID: 16321991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of human FAF1 UBX domain reveals a novel FcisP touch-turn motif in p97/VCP-binding region.
    Kang W; Yang JK
    Biochem Biophys Res Commun; 2011 Apr; 407(3):531-4. PubMed ID: 21414298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central pore residues mediate the p97/VCP activity required for ERAD.
    DeLaBarre B; Christianson JC; Kopito RR; Brunger AT
    Mol Cell; 2006 May; 22(4):451-62. PubMed ID: 16713576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and mechanistic insights into the arginine/lysine-rich peptide motifs that interact with P97/VCP.
    Liu S; Fu QS; Zhao J; Hu HY
    Biochim Biophys Acta; 2013 Dec; 1834(12):2672-8. PubMed ID: 24100225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ER-associated degradation via p97/VCP-interacting motif.
    Ballar P; Fang S
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):818-22. PubMed ID: 18793143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular perspectives on p97-VCP: progress in understanding its structure and diverse biological functions.
    Wang Q; Song C; Li CC
    J Struct Biol; 2004; 146(1-2):44-57. PubMed ID: 15037236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New ATPase regulators--p97 goes to the PUB.
    Madsen L; Seeger M; Semple CA; Hartmann-Petersen R
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2380-8. PubMed ID: 19497384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational changes of the multifunction p97 AAA ATPase during its ATPase cycle.
    Rouiller I; DeLaBarre B; May AP; Weis WI; Brunger AT; Milligan RA; Wilson-Kubalek EM
    Nat Struct Biol; 2002 Dec; 9(12):950-7. PubMed ID: 12434150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The common phospholipid-binding activity of the N-terminal domains of PEX1 and VCP/p97.
    Shiozawa K; Goda N; Shimizu T; Mizuguchi K; Kondo N; Shimozawa N; Shirakawa M; Hiroaki H
    FEBS J; 2006 Nov; 273(21):4959-71. PubMed ID: 17018057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.